B

Bioton SA
WSE:BIO

Watchlist Manager
Bioton SA
WSE:BIO
Watchlist
Price: 2.81 PLN -3.77% Market Closed
Market Cap: 241.3m PLN
Have any thoughts about
Bioton SA?
Write Note

Bioton SA
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bioton SA
Depreciation & Amortization Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
B
Bioton SA
WSE:BIO
Depreciation & Amortization
zł35.8m
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
27%
M
Mabion SA
WSE:MAB
Depreciation & Amortization
zł8.2m
CAGR 3-Years
-2%
CAGR 5-Years
-6%
CAGR 10-Years
22%
R
Read Gene SA
WSE:RDG
Depreciation & Amortization
zł462k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
G
Genomed SA
WSE:GEN
Depreciation & Amortization
zł618.6k
CAGR 3-Years
-4%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
U
Urteste SA
WSE:URT
Depreciation & Amortization
zł776k
CAGR 3-Years
273%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Synthaverse SA
WSE:SVE
Depreciation & Amortization
zł6.6m
CAGR 3-Years
4%
CAGR 5-Years
-28%
CAGR 10-Years
14%
No Stocks Found

Bioton SA
Glance View

Market Cap
241.3m PLN
Industry
Biotechnology

BIOTON SA engages in the manufacture and production of medicine and pharmaceutical substances. The company is headquartered in Warsaw, Woj. Mazowieckie and currently employs 371 full-time employees. The company went IPO on 2005-03-16. The firm is engaged in research, development and wholesale trade of pharmaceutical and biotechnological products. The firm's portfolio consists of oral hypoglycemic drugs (metformin and glimepride) as well as recombinant human insulin in pharmaceutical substance form and for injections. Additionally, the Company provides advertising services. As of December 31, 2011, the Company formed a capital group and operated through its subsidiaries, including BIOTON TRADE Sp. z o.o., Mindar Holdings Ltd, Germonta Holdings Ltd, Tricel SA, SciGen Ltd and BioPartners Holdings AG, among others. On June 12, 2014, it sold a 50% stake in Copernicus Sp. z o.o.

BIO Intrinsic Value
2.83 PLN
Undervaluation 1%
Intrinsic Value
Price
B

See Also

What is Bioton SA's Depreciation & Amortization?
Depreciation & Amortization
35.8m PLN

Based on the financial report for Sep 30, 2024, Bioton SA's Depreciation & Amortization amounts to 35.8m PLN.

What is Bioton SA's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
27%

Over the last year, the Depreciation & Amortization growth was 4%. The average annual Depreciation & Amortization growth rates for Bioton SA have been 4% over the past three years , 3% over the past five years , and 27% over the past ten years .

Back to Top